Core Viewpoint - The A-share IPO market has demonstrated strong resilience and vitality in 2023, with significant growth in both the number of new listings and the total funds raised, despite a complex global macroeconomic environment [3][4]. Summary by Sections IPO Market Performance - In the first three quarters of 2023, a total of 75 new stocks were issued in the A-share market, an increase from 69 in the same period last year, indicating a steady upward trend [4]. - The total funds raised through IPOs reached 743.72 billion yuan, a year-on-year increase of 265 billion yuan, primarily driven by Huadian New Energy's fundraising of 181.71 billion yuan [3][4]. - The average first-day increase for the 75 new stocks was 244%, nearly doubling from the previous year's average [9]. Financing Structure - The financing structure of new stocks shows a pattern of "one company dominating, with smaller averages," where the average and median financing amounts were 9.92 million yuan and 5.5 million yuan, respectively [4]. - Huadian New Energy's IPO accounted for 24.4% of the total financing amount, highlighting its significant impact on the market [4]. Market Trends and Investor Sentiment - The overall market environment has improved, with increased risk appetite and high-quality new stocks contributing to the notable rise in the "money-making effect" of new listings [12]. - Major stock indices, including the Sci-Tech 50 and ChiNext, have risen by over 50% this year, boosting investor confidence and leading to higher valuation premiums for new stocks [12]. Notable New Listings - Several new stocks have seen exceptional performance, with some offering returns exceeding five times their issue price, such as Haibo Sichuang and Ying Shi Innovation [11]. - The top-performing new stocks are primarily in popular sectors, such as energy storage, which has attracted significant investor interest [11]. Global Comparison - The Hong Kong Stock Exchange led the global IPO financing rankings with over 180 billion HKD raised from 66 new stocks, while the Shanghai Stock Exchange ranked fifth globally with 454 billion yuan raised from 25 new stocks [8][7].

Core Viewpoint - The A-share IPO market has demonstrated strong resilience and vitality in 2023, with significant fundraising achievements despite a complex global macroeconomic environment. Group 1: IPO Market Performance - In the first three quarters of 2023, A-shares issued 75 new stocks, an increase from 69 in the same period last year, indicating a steady upward trend [1][2] - The total fundraising amount for IPOs reached 743.72 billion yuan, a year-on-year increase of 265 billion yuan, primarily driven by Huadian New Energy's 181.71 billion yuan fundraising [1][2] - The average first-day increase for the 75 new stocks was 244%, nearly 100 percentage points higher than the same period last year, with no new stock experiencing a decline on its debut [1][2][10] Group 2: Fundraising Structure - The fundraising structure showed a pattern of "one company dominating, with smaller averages," where the average and median fundraising amounts were 9.92 million yuan and 5.5 million yuan, respectively [2][3] - Huadian New Energy was the only large-scale IPO this year, accounting for 24.4% of the total fundraising amount [2][3] Group 3: Sector Analysis - The ChiNext board led in the number of IPOs with 27 new stocks raising a total of 195.34 billion yuan, while the Shanghai Stock Exchange's main board led in total fundraising with 372.84 billion yuan [5] - The Hong Kong Stock Exchange ranked first globally in IPO fundraising, with 66 new stocks raising over 180 billion HKD, and four of the top five fundraising companies were A-share listed companies going public in Hong Kong [6] Group 4: Investor Sentiment and Market Trends - The significant increase in the "money-making effect" of new stocks is attributed to an overall market recovery, increased risk appetite, and the high quality of new stocks [10] - Major indices in the A-share market have rebounded, with the ChiNext 50, ChiNext Index, and North Exchange 50 rising over 50% this year, boosting investor confidence [10]

Group 1 - The A-share IPO market is active, with 72 companies listed by September 22, raising a total of 69.644 billion yuan, surpassing the total fundraising amount for the entire year of 2024 [2][3] - The Hong Kong market has seen 64 companies listed, raising a total of 146.887 billion HKD (approximately 134.325 billion yuan), exceeding the total for both 2023 and 2024 [2][3] - Deloitte's report indicates that the Hong Kong Stock Exchange will continue to lead global IPO financing rankings, driven by six large IPOs during the period [3][10] Group 2 - In the first three quarters, A-shares are expected to have 78 new IPOs raising 77.1 billion yuan, a 13% increase in the number of IPOs and a 61% increase in total fundraising compared to the same period last year [3][9] - The Hong Kong market is projected to have 66 new IPOs raising 1.823 billion HKD (approximately 1.668 billion yuan), representing a 228% year-on-year increase in fundraising [3][9] Group 3 - Major IPOs in 2023 include CATL, Zijin Mining International, Huadian New Energy, and others, with Huadian New Energy's IPO being the largest in A-shares this year at 18.1 billion yuan [5][11] - The A-share market is seeing a shift in industry focus, with traditional and high-end manufacturing sectors leading in both the number of IPOs and fundraising amounts [7][9] Group 4 - The number of IPO withdrawals has significantly decreased, with 83 companies withdrawing their IPOs this year, a 77.13% decline year-on-year [9] - As of September 19, there are 279 companies waiting for IPO approval in the A-share market, with 50 companies having been reviewed and 49 approved [9] Group 5 - The Hong Kong market is benefiting from policies encouraging mainland companies to list there and the optimization of the IPO application process, leading to a strong market momentum [10][13] - Deloitte forecasts that over 80 new IPOs will be listed in Hong Kong in 2025, raising between 250 billion to 280 billion HKD [13][14]

格隆汇9月23日丨根据联交所最新权益披露资料显示，2025年9月19日，三花智控(02050.HK)遭Schroders PLC在场内以每股均价38.208港元减持341.67万股， 涉资约1.31亿港元。 减持后，Schroders PLC最新持股数目为6587.94万股，持股比例由14.54%下降至13.82%。 | 表格序號 | 大股東/董事/最高行政人員名 作出披露的 買入 / 賣出或涉及的 每股的平均價 | | | | | 持有權益的股份數目 佔已發行的 有關事件的日期 相 | | | --- | --- | --- | --- | --- | --- | --- | --- | | | | 原因 | 股份數目 | | | ( 請参関上犹* 註 | 有投票權股 (日 / 月 / 年) | | | | | | | | | 份自分比 | | | | | | | | | (96) | | CS20250922E00221 | Schroders PLC | 1201(L) | | 3.416.700(L) | HKD 38.2080 | 65.879.400(L) | 13.82(L) 19/09/202 ...

Group 1 - Schroders PLC reduced its stake in Sanhua Intelligent Control (02050.HK) by selling 3.4167 million shares at an average price of HKD 38.208 per share, amounting to approximately HKD 131 million [1] - Following the sale, Schroders PLC's total shareholding decreased to 65.8794 million shares, resulting in a reduction of its ownership percentage from 14.54% to 13.82% [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 就 因 本 公 告 全 部或任何部分內容所產生或因依賴該等內容而引致的任何損失承擔任何責任。 ZHEJIANG SANHUA INTELLIGENT CONTROLS CO., LTD. 浙江三花智能控制股份有限公司 （於 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司） （股 份 代 號：2050） 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條 而 做 出。 茲載列浙江三花智能控制股份有限公司於深圳證券交易所網站(www.szse.cn)刊 登 的 公 告 如 下，僅 供 參 閱。 承董事會命 浙江三花智能控制股份有限公司 董事長兼執行董事 張亞波 香 港，2025 年9 月19日 於本公告日 期，董事會包 括 (i)執行董事張亞波先 生、王大勇先 生、倪曉明先生 及陳雨忠先 生；(ii)非執行董事張少波先生及任金土先生 及 (iii)獨立非執行董事 鮑恩斯先 生、石建輝先 生、潘亞 ...

Group 1 - Some robotics concept stocks experienced a decline in early trading, with Sanhua Intelligent Control (02050) down 6.21% at HKD 38.38 and Delta Electronics (00179) down 4.61% at HKD 37.66 [1] - There are reports that US plant-based pharmaceutical company PharmAGRI signed a letter of intent with Tesla to deploy up to 10,000 Optimus Gen3+ humanoid robots in its self-operated farms and prescription drug production [1] - Elon Musk responded on social media, labeling the PharmAGRI news as false, but he previously mentioned plans for a technical review of Tesla's AI5 chip design this Saturday and a meeting related to robotics next week [1] Group 2 - On September 18, the Minister of Science and Technology, Yin Hejun, stated that efforts are being made to accelerate the application of humanoid robots in automotive manufacturing, logistics handling, and power inspection, laying a solid foundation for the future trillion-level industry development [1]

Major Events - Jinfang Pharmaceutical-B (02595) received a subscription rate of 2662.79 times for its public offering in Hong Kong, raising approximately HKD 1.67 billion from the global offering [1] - Heng Rui Pharmaceutical (01276) announced that its SHR-1501 injection has been included in the list of proposed breakthrough therapy products [1] - Shanghai Pharmaceuticals (02607) successfully passed the consistency evaluation for the generic drug Nicorandil tablets [1] - Qutech Technology (01478) plans to sell 51.08% of its stake in India for INR 5.53 billion [1] - Boleton (01333) signed a procurement contract for energy storage system equipment with Guoxia Technology [1] - Hongye Futures (03678) shareholders Suhao Huihong and Hongye Logistics collectively reduced their holdings by 5.9482 million shares [1] - Shangu Holdings (00412) responded to concerns about concentrated shareholding, stating that the company can comply with public shareholding regulations [1] - Changfei Optical Fiber and Cable (06869) experienced unusual stock price fluctuations, with its hollow core fiber business not yet significantly impacting financial data [1] - Sanhua Intelligent Control (02050) reported abnormal trading fluctuations in A-shares, confirming no undisclosed significant matters or ongoing major planning [1] Operating Performance - China Pacific Insurance (02601) reported that its life insurance premium income for the first eight months reached CNY 217.05 billion, a year-on-year increase of 13.2% [1] - Datang Renewable (01798) completed a power generation volume of 2.1691 million MWh in August, representing a year-on-year increase of 27.5% [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 就 因 本 公 告 全 部或任何部分內容所產生或因依賴該等內容而引致的任何損失承擔任何責任。 ZHEJIANG SANHUA INTELLIGENT CONTROLS CO., LTD. 浙江三花智能控制股份有限公司 （於 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司） （股 份 代 號：2050） 海外監管公告 证券代码：002050 证券简称：三花智控 公告编号：2025-087 浙江三花智能控制股份有限公司 关于股价异动的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條 而 做 出。 茲載列浙江三花智能控制股份有限公司於深圳證券交易所網站(www.szse.cn)刊 登 的 公 告 如 下，僅 供 參 閱。 承董事會命 浙江三花智能控制股份有限公司 董事長兼執行董事 張亞波 香 港，2025 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示 概 不 就 因 本 公 告 全 部或任何部分內容所產生或因依賴該等內容而引致的任何損失承擔任何責任。 於本公告日 期，董事會包 括 (i)執行董事張亞波先 生、王大勇先 生、倪曉明先生 及陳雨忠先 生；(ii)非執行董事張少波先生及任金土先生 及 (iii)獨立非執行董事 鮑恩斯先 生、石建輝先 生、潘亞嵐女士以及葛俊先 生。 ZHEJIANG SANHUA INTELLIGENT CONTROLS CO., LTD. 浙江三花智能控制股份有限公司 （於 中 華 人 民 共 和 國 註 冊 成 立 的 股 份 有 限 公 司） （股 份 代 號：2050） 海外監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條 而 做 出。 茲載列浙江三花智能控制股份有限公司於深圳證券交易所網站(www.szse.cn)刊 登 的 公 告 如 下，僅 供 參 閱。 承董事會命 浙江三花智能控制股份有限公司 董事長兼執行董事 張亞波 香 港，2 ...